Persona Ti-Nidium Post-Market Clinical Follow-up

NAActive, not recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

May 31, 2034

Study Completion Date

May 31, 2034

Conditions
Knee Pain ChronicOsteoarthritisRheumatoid ArthritisTraumatic ArthritisPolyarthritisVarus DeformityValgus DeformityFlexion Deformity of the KneeAvascular NecrosisPatellofemoral Osteoarthritis
Interventions
DEVICE

Zimmer Biomet Persona Ti-Nidium Total Knee System

Primary Knee Total Arthroplasty

Trial Locations (7)

19107

Rothman Orthopaedic Institute, Philadelphia

20782

MedStar Health Research Institute, Hyattsville

27708

Duke University, Durham

39202

Mississippi Sports Medicine and Orthopaedic Center, Jackson

57701

Monument Health Rapid City Hospital, Inc., Rapid City

80134

Denver Hip & Knee, Inc., Parker

87110

New Mexico Orthopaedic Associates, Albuquerque

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT04817969 - Persona Ti-Nidium Post-Market Clinical Follow-up | Biotech Hunter | Biotech Hunter